
Researchers from Meijo University (led by Professor Takeshi Ohura, with graduate student Natsuki Nasuda) and the National Institute of Animal Health (Dr. Keerthi S. Guruge) have identified bromochloropyrene (BrClPy) as an environmental contaminant in industrial soils and sediments in Japan.
It is a hetero- halogenated (mixed bromine- and chlorine- containing) polycyclic aromatic hydrocarbon (PAH) with hybrid properties that do not simply match those of purely brominated or chlorinated analogs.
Key findings
- Occurrence: BrClPy was detected in 10 of 20 surface soil samples from industrial areas along Tokyo Bay (mean concentration 0.13 ng/g) and in 1 of 3 sediment samples from Nagoya Port (mean 0.42 ng/g). Soil concentrations correlated strongly with brominated pyrenes, suggesting formation is more closely tied to bromination processes than to chlorinated pyrenes.
- Photostability: Under simulated sunlight, BrClPy was roughly half as stable as 1-chloropyrene (similar to the behavior of brominated pyrenes). It primarily lost bromine, forming 1-chloropyrene; loss of chlorine was not observed.
- Biological activity: In a yeast- based aryl hydrocarbon receptor (AhR) assay, BrClPy showed an estimated potency of 0.18 relative to benzo[a]pyrene. This was similar to dichloropyrene and about 4- 5 times higher than dibromopyrene.
Overall, BrClPy combines the environmental and photolytic behavior of brominated pyrenes with the stronger AhR-mediated activity more typical of chlorinated ones. This points to “emergent” properties of hetero -halogenated PAHs that cannot be predicted from single -halogen compounds alone.
The work (published online September 22, 2026, in Emerging Contaminants, DOI: 10.1016/j.emcon.2026.100758) provides the first evidence of BrClPy contamination in real urban/industrial soils and sediments.
The authors note that monitoring programs may currently overlook mixed-halogen pollutants and call for further research on formation pathways, environmental fate, and biological effects of related compounds to improve risk assessment and regulation.
The study was supported by Japan Society for the Promotion of Science KAKENHI grants.

The discovery of bromochloropyrene (BrClPy) has primarily precautionary implications for human health rather than demonstrated acute or widespread risks at current environmental levels.
Direct human toxicity data for BrClPy do not yet exist, as it is a newly identified contaminant. Implications are inferred from its aryl hydrocarbon receptor (AhR) activity, its classification as a hetero- halogenated PAH, and the broader toxicology of related halogenated PAHs (HPAHs or XPAHs).
AhR- mediated activity and potential effects
BrClPy activates the AhR with an estimated relative potency of 0.18 compared with benzo[a]pyrene (BaP) in a recombinant yeast assay. This is comparable to dichloropyrene and roughly 4- 5 times higher than dibromopyrene.
AhR is a ligand- activated transcription factor involved in the toxicity of dioxins, certain PCBs, and many PAHs/HPAHs. Chronic activation is associated with:
- Carcinogenicity (via induction of CYP enzymes, oxidative stress, and related pathways).
- Endocrine disruption.
- Immunotoxicity.
- Developmental and reproductive effects (observed in various model systems for AhR agonists).
BaP itself is an IARC Group 1 human carcinogen, so a compound with measurable relative potency raises concern as a potential contributor to dioxin-like or PAH- like toxicity.
Halogenated PAHs frequently show higher AhR potency than their parent (non-halogenated) counterparts in mammalian and other assays, and they are considered to possess dioxin- like properties.
Exposure context and risk levels
Detected concentrations were low: mean ~0.13 ng/g in industrial soils and ~0.42 ng/g in one harbor sediment sample.
These levels suggest limited direct human exposure via soil contact or dust under typical conditions. Possible routes include:
- Inhalation of combustion- related particles (HPAHs form during incomplete combustion).
- Ingestion via contaminated food (bioaccumulation potential in the food chain is a general concern for persistent HPAHs).
- Dermal contact with soils and sediments in industrial or urban areas.
For the broader class of HPAHs and XPAHs, dietary and indoor air and dust exposure assessments have generally found incremental lifetime cancer risks (ILCR) below or near common thresholds (e.g., 10⁻⁶ to 10⁻⁴) for individual compounds or matrices. However, cumulative risks from multiple PAHs and HPAHs can approach or exceed unacceptable levels in some scenarios.
No quantitative human risk assessment specifically for BrClPy is available yet.
Broader implications
- Monitoring and regulation gaps: Current environmental monitoring often focuses on parent PAHs or single- halogen compounds and may miss mixed-halogen species like BrClPy. The researchers note that better characterization could improve estimates of human exposure and associated effects, potentially informing future regulations.
- Additive or synergistic effects: BrClPy’s hybrid photolytic and biological behavior (brominated- like environmental persistence and photolysis combined with stronger chlorinated- like AhR activity) means it may contribute to overall toxic load in ways not fully captured by existing toxic equivalency factors (TEQs) based solely on chlorinated or brominated analogs.
- Research needs: Further studies are required on bioaccumulation, metabolic activation, chronic toxicity, and actual human biomarkers of exposure. Related work on other HPAHs supports structure–activity relationships linking halogenation pattern and position to AhR potency and downstream effects (e.g., enzyme induction, oxidative stress).
In summary, BrClPy is unlikely to pose significant individual health risks at the trace levels reported, but it adds to the cumulative burden of AhR- active environmental contaminants. Its identification highlights the value of expanding monitoring to hetero- halogenated PAHs for more accurate long-term risk assessment, particularly in industrial and urban settings with combustion sources.

Hetero-halogenated polycyclic aromatic hydrocarbons as environmental contaminants: Occurrences, photostability, and AhR-mediated activity of bromochloropyrene – ScienceDirect
The aryl hydrocarbon receptor (AhR, also called AHR) is a ligand- activated transcription factor of the basic helix- loop-helix and Per- ARNT-Sim (bHLH- PAS) family.
It functions as an environmental and endogenous sensor. Originally identified as the mediator of toxicity from dioxins (e.g., TCDD), polycyclic aromatic hydrocarbons (PAHs), and related compounds (including halogenated PAHs such as bromochloropyrene), it also responds to dietary, microbial, and metabolic ligands and regulates diverse physiological processes.
Canonical (genomic) pathway
This is the primary and best-characterized mechanism:
- Inactive cytoplasmic complex: In the absence of ligand, AhR resides in the cytoplasm as part of a multiprotein complex. This typically includes:
- Two molecules of heat shock protein 90 (HSP90)
- Co-chaperone p23 (PTGES3)
- AhR-interacting protein (AIP/XAP2/ARA9)
- Often the tyrosine kinase c-Src
HSP90 stabilizes AhR, prevents degradation, and masks its nuclear localization signal (NLS).
- Ligand binding: Agonists (environmental toxins like TCDD, BaP, or BrClPy; endogenous ligands such as FICZ, kynurenine, or microbial metabolites) bind the PAS- B domain. This triggers a conformational change that exposes the NLS and promotes dissociation (or rearrangement) of chaperones.
- Nuclear translocation: The ligand- bound AhR moves into the nucleus (sometimes still associated with HSP90 initially).
- Heterodimerization: AhR partners with the AhR nuclear translocator (ARNT, also known as HIF- 1β). Structural studies show intimate PAS-B domain interactions between AhR and ARNT in the active complex.
- DNA binding and transcription: The AhR– ARNT heterodimer binds xenobiotic and dioxin response elements (XREs and DREs; core motif typically 5′-TNGCGTG- 3′ or similar) in the regulatory regions of target genes. It recruits co- activators and the transcriptional machinery, inducing expression of genes such as:
- Phase I enzymes: CYP1A1, CYP1A2, CYP1B1
- Phase II enzymes and other adaptive genes
- Negative regulators (e.g., AhR repressor/AHRR, TIPARP)
- Feedback and termination: Induced CYP enzymes metabolize many ligands (creating a negative feedback loop). AhR itself is subject to ubiquitination and proteasomal degradation. AHRR can compete with AhR for ARNT or DNA binding.
Ligand potency, residence time, and structure influence the strength and duration of the response. Persistent ligands like TCDD produce prolonged activation and more severe toxicity than rapidly metabolized ones like many PAHs.
Non- canonical pathways
AhR signaling is highly context-dependent (cell type, ligand, microenvironment) and extends beyond the classic AhR– ARNT– XRE route:
- c- Src release and kinase signaling: Ligand binding can free c- Src from the cytoplasmic complex. c- Src then phosphorylates targets such as the epidermal growth factor receptor (EGFR), activating downstream MAPK or other pathways.
- Crosstalk with other transcription factors: AhR can interact with NF- κB, estrogen receptor (ER), HIF- 1α (competing for ARNT under hypoxia), STATs, or others, leading to trans- repression or alternative gene sets.
- Non- XRE DNA binding: Partnerships with factors such as KLF6 at non-canonical response elements can drive distinct epigenetic and transcriptional outcomes (e.g., cell- cycle regulation via p21).
- E3 ubiquitin ligase activity: Ligand- activated AhR can promote ubiquitination and degradation of specific proteins (including itself or other targets).
- Ligand- independent or stress- induced activation: Mechanical stress, oxidative stress, or other signals can sometimes activate AhR without classical ligands.
- Cytoplasmic or membrane- proximal effects: Additional non- genomic actions contribute to rapid responses.
Physiological and pathological roles
AhR integrates environmental and endogenous signals. Beyond xenobiotic metabolism and toxicity (carcinogenesis, developmental disruption, immunotoxicity via prolonged activation by pollutants), it regulates:
- Immune responses (Treg, Th17 balance, barrier integrity, inflammation)
- Development and tissue homeostasis
- Host– microbe interactions and diet sensing (tryptophan metabolites)
- Cancer (context- dependent tumor promotion or suppression)
Therapeutic interest has grown: the AhR agonist tapinarof is approved for psoriasis, and other modulators are in trials for inflammatory diseases, cancer, and infections.
In the context of compounds like bromochloropyrene, AhR activation (measured by reporter assays or CYP induction) serves as a key indicator of potential dioxin- like biological activity and toxicity risk, even though full downstream effects depend on dose, duration, tissue, and co-exposures.
Structural advances continue to clarify ligand recognition (promiscuous but with conserved residues in the PAS- B pocket) and the transition from chaperone- bound to ARNT- bound states, aiding both toxicology and drug design.

Hetero-halogenated polycyclic aromatic hydrocarbons as environmental contaminants: Occurrences, photostability, and AhR-mediated activity of bromochloropyrene – ScienceDirect
Hetero-halogenated polycyclic aromatic hydrocarbons as environmental contaminants: Occurrences, photostability, and AhR-mediated activity of bromochloropyrene
This is the peer- reviewed paper underlying the Meijo University press release we discussed earlier.
Main findings (from the abstract, press materials, and available excerpts)
Researchers synthesized a reference standard of bromochloropyrene (BrClPy; tentatively a mixture of 1- bromo- 6- chloropyrene and 1- bromo- 8-chloropyrene) for the first time and used it to analyze environmental samples.
- Occurrence: Detected in 10 of 20 surface soil samples from industrial areas along Tokyo Bay (mean 0.13 ng/g; range <LOD–1.21 ng/g) and in 1 of 3 sediment samples from Nagoya Port (0.42 ng/g mean; one sample 1.27 ng/g). This provides the first evidence of hetero-halogenated (mixed Brand Cl) PAHs in real urban and industrial soils and sediments. Concentrations correlated strongly with brominated pyrenes (1- BrPy and Br₂Py), suggesting formation pathways more similar to bromination processes.
- Photostability: Under simulated sunlight, BrClPy followed first- order kinetics with a photolysis rate constant of ~0.162 h⁻¹. Photostability was approximately half that of 1- chloropyrene (and similar to 1-bromopyrene and dibromopyrene). The dominant pathway was debromination, producing 1-chloropyrene; dechlorination products were not observed.
- AhR- mediated activity: In a recombinant yeast assay, BrClPy showed a dose–response relationship (EC₅₀ ≈ 0.43 μM) with a relative potency (REP_BaP) of 0.18 versus benzo[a]pyrene. This was similar to dichloropyrene (REP ≈ 0.20) and 4- 5 times higher than dibromopyrene (REP ≈ 0.04).
Conclusion of the study: BrClPy exhibits hybrid (“emergent”) properties—environmental behavior and photolysis resembling brominated pyrenes, but biological (AhR) activity closer to chlorinated pyrenes. The authors highlight the need for further research on formation, fate, and effects of other hetero-halogenated PAHs to improve monitoring and risk assessment.
Funding came from Japan Society for the Promotion of Science KAKENHI grants 23K21754 and 25K15471.
The full text is behind ScienceDirect’s access controls for many users (institutional or personal subscription and open- access options may apply).
The key results and conclusions are publicly summarized in the EurekAlert release and research- map excerpts.
Title: Hetero-halogenated polycyclic aromatic hydrocarbons as environmental contaminants: Occurrences, photostability, and AhR-mediated activity of bromochloropyrene
Journal: Emerging Contaminants, Volume 12, Issue 4,
Published: December 2026; available online 22 September 2026
DOI: 10.1016/j.emcon.2026.100758
ScienceDirect PII: S240566502600137X
Provided: Meijo University
Authors: Natsuki Nasuda a, Keerthi S. Guruge b, Takeshi Ohura a
aGraduate School of Agriculture, Meijo University, 1-501 Shiogamaguchi, Nagoya, 468-8502, Japan
bDivision of Hygiene Management Research, National Institute of Animal Health, National Agriculture and Food Research Organization, 3-1-5 Kannondai, Tsukuba, 305-0856, Japan
Abstract
Homo-halogenated polycyclic aromatic hydrocarbons (HPAHs), such as chlorine- or bromine-substituted PAHs, have been ubiquitously distributed in the environment. Conversely, hetero-halogenated PAHs, including chlorine- and bromine-substituted PAHs (halomix PAHs), have not been reported to occur in the environment. This study investigated the environmental occurrence and behavior of bromochloropyrene (BrClPy) as a representative halomix PAH. A BrClPy standard (tentatively a mixture of 1-bromo-6-chloropyrene and 1-bromo-8-chloropyrene) was synthesized for the first time and used for environmental analysis. BrClPy was frequently detected in environmental samples, with mean concentrations of 0.13 ng/g in surface soils from industrial areas and 0.42 ng/g in sediments from industrial harbors. The photostability of BrClPy under simulated sunlight was approximately twofold lower than that of 1-chloropyrene, which was somewhat consistent with the photostability values obtained for 1-bromopyrene and dibromopyrene. The aryl hydrocarbon receptor-mediated activity of BrClPy measured using a recombinant yeast assay showed a potency close to that of dichloropyrene rather than dibromopyrene with an estimated potency of 0.18 relative to benzo[a]pyrene. Consequently, the environmental behavior and biological properties of BrClPy could exhibit the combined characteristics of brominated and chlorinated pyrene.







You must be logged in to post a comment.